Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of August 2026

  1. Mirum Pharmaceuticals

    World Rank (Aug-2026)
    3,000
    Market Cap (Aug-2026)
    6.535 Billion USD
    World Rank (Jan-05-2024)
    7,121
    Market Cap (Jan-05-2024)
    1.384 Billion USD
    World Rank (Jul-30-2023)
    8,800
    Market Cap (Jul-30-2023)
    0.988 Billion USD
    World Rank (Dec-25-2022)
    10,559
    Market Cap (Dec-25-2022)
    0.673 Billion USD
    World Rank (Jan-07-2022)
    13,731
    Market Cap (Jan-07-2022)
    0.48 Billion USD
    Annual Revenue in USD
    521 Million USD
    Annual Operating Income in USD
    -22 Million USD
    Annual Net Income in USD
    -23 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Mirum Pharmaceuticals is a Clinical Stage Biopharmaceutical company focused on clinical studies for the treatment of cholestatic diseases including primary sclerosing cholangitis (PSC), intrahepatic cholestasis of pregnancy (ICP) and primary biliary cholangitis (PBC). It is having 24 employees as on 2019. The headquarters is in USA.
    Company Website
    MIRUM PHARMACEUTICALS

  2. Dianthus Therapeutics Inc.

    World Rank (Aug-2026)
    3,017
    Market Cap (Aug-2026)
    6.486 Billion USD
    World Rank (Jan-05-2024)
    18,106
    Market Cap (Jan-05-2024)
    0.193 Billion USD
    World Rank (Jul-30-2023)
    18,141
    Market Cap (Jul-30-2023)
    0.189 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -178 Million USD
    Annual Net Income in USD
    -162 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Website
    Dianthus Therapeutics Inc.

  3. Erasca Inc.

    World Rank (Aug-2026)
    3,039
    Market Cap (Aug-2026)
    6.429 Billion USD
    World Rank (Jan-05-2024)
    15,262
    Market Cap (Jan-05-2024)
    0.326 Billion USD
    World Rank (Jul-30-2023)
    14,247
    Market Cap (Jul-30-2023)
    0.392 Billion USD
    World Rank (Dec-25-2022)
    11,784
    Market Cap (Dec-25-2022)
    0.552 Billion USD
    World Rank (Jan-07-2022)
    7,273
    Market Cap (Jan-07-2022)
    1.56 Billion USD
    Annual Operating Income in USD
    -141 Million USD
    Annual Net Income in USD
    -125 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Erasca, Inc is a clinical stage precision oncology company singularly focused on discovering, developing and commercializing therapies driven cancers. The headquarters is in USA.

    Company Website
    ERASCA, INC.

  4. Belite Bio Inc

    World Rank (Aug-2026)
    3,042
    Market Cap (Aug-2026)
    6.405 Billion USD
    World Rank (Jan-05-2024)
    7,954
    Market Cap (Jan-05-2024)
    1.137 Billion USD
    World Rank (Jul-30-2023)
    11,043
    Market Cap (Jul-30-2023)
    0.656 Billion USD
    World Rank (Dec-25-2022)
    9,808
    Market Cap (Dec-25-2022)
    0.768 Billion USD
    Annual Operating Income in USD
    -84 Million USD
    Annual Net Income in USD
    -78 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on aging metabolic diseases including dry age related macular degeneration, liver disease and diabetes. The headquarters is in United States.
    Company Website
    Belite Bio Inc

  5. Amneal Pharmaceuticals

    World Rank (Aug-2026)
    3,076
    Market Cap (Aug-2026)
    6.322 Billion USD
    World Rank (Jan-05-2024)
    6,045
    Market Cap (Jan-05-2024)
    1.809 Billion USD
    World Rank (Jul-30-2023)
    8,910
    Market Cap (Jul-30-2023)
    0.965 Billion USD
    World Rank (Dec-25-2022)
    15,083
    Market Cap (Dec-25-2022)
    0.333 Billion USD
    World Rank (Jan-07-2022)
    11,500
    Market Cap (Jan-07-2022)
    0.69 Billion USD
    Annual Revenue in USD
    3,019 Million USD
    Annual Operating Income in USD
    394 Million USD
    Annual Net Income in USD
    72 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile
    Amneal Pharmaceuticals is an Integrated Specialty Pharmaceutical company. It is powered by a robust U.S. generics business and a growing branded business and focused on delivering outcomes that meet important medical needs, make quality medicines more accessible and more affordable and provide solutions for tomorrows health challenges. The headquarters is in USA.
    Company Website
    AMNEAL PHARMACEUTICALS INC

  6. Xenon Pharmaceuticals

    World Rank (Aug-2026)
    3,179
    Market Cap (Aug-2026)
    6.038 Billion USD
    World Rank (Jan-05-2024)
    3,922
    Market Cap (Jan-05-2024)
    3.464 Billion USD
    World Rank (Jul-30-2023)
    5,199
    Market Cap (Jul-30-2023)
    2.331 Billion USD
    World Rank (Dec-25-2022)
    4,829
    Market Cap (Dec-25-2022)
    2.382 Billion USD
    World Rank (Jan-07-2022)
    7,271
    Market Cap (Jan-07-2022)
    1.57 Billion USD
    Annual Revenue in USD
    32 Million USD
    Annual Net Income in USD
    -28 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Canada
    Yahoo @ Nasdaq
    Company Profile
    Xenon Pharmaceuticals is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The headquarters is in Canada.
    Company Website
    XENON PHARMACEUTICALS

  7. Kiniksa Pharmaceuticals

    World Rank (Aug-2026)
    3,203
    Market Cap (Aug-2026)
    5.988 Billion USD
    World Rank (Jan-05-2024)
    7,059
    Market Cap (Jan-05-2024)
    1.405 Billion USD
    World Rank (Jul-30-2023)
    7,387
    Market Cap (Jul-30-2023)
    1.325 Billion USD
    World Rank (Dec-25-2022)
    8,029
    Market Cap (Dec-25-2022)
    1.075 Billion USD
    World Rank (Jan-07-2022)
    10,948
    Market Cap (Jan-07-2022)
    0.76 Billion USD
    Annual Revenue in USD
    38 Million USD
    Annual Net Income in USD
    -157 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Bermuda
    Yahoo @ Nasdaq
    Company Website
    KINIKSA PHARMACEUTICALS

  8. PTC Therapeutics Inc.

    World Rank (Aug-2026)
    3,206
    Market Cap (Aug-2026)
    5.984 Billion USD
    World Rank (Jan-05-2024)
    5,486
    Market Cap (Jan-05-2024)
    2.120 Billion USD
    World Rank (Jul-30-2023)
    4,320
    Market Cap (Jul-30-2023)
    3.037 Billion USD
    World Rank (Dec-25-2022)
    4,471
    Market Cap (Dec-25-2022)
    2.661 Billion USD
    World Rank (Jan-07-2022)
    5,237
    Market Cap (Jan-07-2022)
    2.69 Billion USD
    Annual Revenue in USD
    1,731 Million USD
    Annual Operating Income in USD
    867 Million USD
    Annual Net Income in USD
    683 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    PTC Therapeutics is a Commercial and Diversified Biopharmaceutical company. It operates offices and research labs in more than 20 countries and occupy a business footprint in more than 50 countries around the world. It is a having 2,20,000 square feet in Hopewell, New Jersey. The headquarters is in USA.

    Company Website
    PTC THERAPEUTICS INC

  9. Ligand Pharmaceuticals

    World Rank (Aug-2026)
    3,242
    Market Cap (Aug-2026)
    5.873 Billion USD
    World Rank (Jan-05-2024)
    7,621
    Market Cap (Jan-05-2024)
    1.227 Billion USD
    World Rank (Jul-30-2023)
    7,940
    Market Cap (Jul-30-2023)
    1.175 Billion USD
    World Rank (Dec-25-2022)
    5,769
    Market Cap (Dec-25-2022)
    1.822 Billion USD
    World Rank (Jan-07-2022)
    5,576
    Market Cap (Jan-07-2022)
    2.42 Billion USD
    Annual Revenue in USD
    268 Million USD
    Annual Operating Income in USD
    41 Million USD
    Annual Net Income in USD
    124 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Ligand Pharmaceuticals is a Biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. It is providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. The headquarters is in USA.
    Company Website
    LIGAND PHARMACEUTICALS INCORPORATED

  10. Travere Therapeutics Inc.

    World Rank (Aug-2026)
    3,245
    Market Cap (Aug-2026)
    5.857 Billion USD
    World Rank (Jan-05-2024)
    10,719
    Market Cap (Jan-05-2024)
    0.683 Billion USD
    World Rank (Jul-30-2023)
    7,507
    Market Cap (Jul-30-2023)
    1.287 Billion USD
    World Rank (Dec-25-2022)
    7,234
    Market Cap (Dec-25-2022)
    1.285 Billion USD
    World Rank (Jan-07-2022)
    6,953
    Market Cap (Jan-07-2022)
    1.70 Billion USD
    Annual Revenue in USD
    491 Million USD
    Annual Operating Income in USD
    -63 Million USD
    Annual Net Income in USD
    -26 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile

    Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life changing therapies to people living with rare disease. The headquarters is in USA.

    Facts About Company

    Travere Therapeutics Annual Total Revenue for year ending Dec-2022 was 212 million USD and and Net loss for year ending Dec-2022 was -278 million USD.

    Travere Therapeutics Annual Total Revenue for year ending Dec-2021 was 227 million USD and and Net loss for year ending Dec-2021 was -180 million USD.

    As on 2022, Travere Therapeutics has 462 employees.

    Company Website
    TRAVERE THERAPEUTICS, INC.

Share